POM-V Prescription Required

Fungitraxx 10 mg/ml oral solution for ornamental birds

Active ingredient: Itraconazole

Form

Liquid

Species

Ornamental Birds

Manufacturer

Avimedical B.V.

VMD MA No.

EU/2/13/160/001–002

What it's used for

Treatment of dermatophytosis caused by Microsporum canis.

Full indications, dosage and side effects ↓

View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Itraconazole

1

Ask your vet for a written prescription

They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
2

Fill it at a registered online retailer

The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Your prescription rights → VMD register of retailers →

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Fungitraxx 10 mg/ml oral solution for ornamental birds — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

Treatment of dermatophytosis caused by Microsporum canis.

The solution is administered orally directly into the mouth by means of a dosing syringe.
The daily dosage is 5 mg/kg or 0.5 ml/kg/day.
The dosage regime is 0.5 ml/kg/day for 3 alternate periods of 7 consecutive days, each
time with 7 days without treatment in between.
days
days
days
days
days
t
reatment
n
o treatment
t
reatment
n
o treatment
t
reatment
The dosing syringe shows graduations per 100 gram of body weight. Fill the syringe by
pulling the plunger until it reaches the graduation corresponding to the correct body weight
of the cat.
When administering the product to kittens, the administrator should be careful not to
administer more than the recommended dose/weight. For kittens weighing less than 0.5
kg, a 1 ml syringe which allows proper dosing should be used.
Treat the animal by slowly and gently injecting the liquid into the mouth, allowing the cat to
swallow the product.
After dosing, the syringe should be removed from the bottle, washed and dried and the
cap should be screwed back on tightly.
Data in humans shows that food intake may result in lower drug absorption. Therefore, it is
recommended to administer the product by preference between meals.
In some cases, a prolonged time between clinical and mycological cure may be observed.
In cases where a positive culture is obtained 4 weeks after the end of administration, the
treatment should be repeated once at the same dosage regimen. In such cases where the
cat is also immunosuppressed, treatment should be repeated and the underlying disease
addressed.

Do not administer to cats with hypersensitivity to itraconazole or one of the other
ingredients.
Do not administer to cats with impaired liver or kidney function.
For use in pregnant and lactating queens: see section 4.7

Common adverse reactions were vomiting, diarrhoea, anorexia, salivation, depression and
apathy. These effects are usually mild and transient. In rare cases a transient increase in
liver enzymes may occur (sometimes fatal). In very rare cases elevated total bilirubin may
occur (sometimes fatal). In very rare cases this was associated with icterus. If clinical signs
suggestive of liver dysfunction develop, treatment should be discontinued immediately.
In very rare cases weight loss may occur.

Some cases of feline dermatophytosis can be difficult to cure, especially in catteries.
Cats treated with itraconazole can still infect other cats with as long as they are
not mycologically cured. It is therefore advised to minimise the risk of re-infection or
spread of infection by keeping healthy animals (including dogs as they can also be
infected by ) separate from cats that are being treated. Cleaning and disinfection
of the environment with appropriate fungicidal products is highly recommended –
especially in case of group problems.

Revised: November 2024
AN: 01058/2024
When clipping the hair of infected cats, the advice of the veterinarian should be sought
first.
Clipping of the hair coat is considered useful because it removes infected hairs, stimulates
new hair growth and hastens recovery. It is strongly recommended that clipping is
performed by a veterinarian. In cases with limited lesions, hair clipping can be limited to
the lesions only, whereas in cats with generalized dermatophytosis it is recommended to
clip the entire hair coat. Care should be taken not to cause trauma to the underlying skin
during clipping. It is recommended that disposable, protective clothing and gloves are worn
during the clipping of the affected animals. The clipping of the hair should be performed in
a well ventilated room which can be disinfected after clipping. The hairs should be
disposed of appropriately and all instruments, clippers etc. should be disinfected.
Treatment of dermatophytosis should not be limited to treatment of the infected animal(s).
It should also include disinfection of the environment with appropriate fungicidal products,
since
such as frequent vacuuming, disinfection of grooming equipment and removal of all
potentially contaminated material that cannot be disinfected will minimize the risk of re-
infection or spread of infection. Disinfection and vacuuming should be continued for an
extended period after the cat is clinically cured, but vacuuming should be limited to
surfaces, which may not be cleaned with a damp cloth. All other surfaces should be
cleaned with a damp cloth. Any cloth used for cleaning should be washed and disinfected
or disposed of and the used vacuum cleaner bag should be disposed of.

Measures to prevent introduction of M.canis
new cats, isolation of cats returning from shows or breeding, exclusion of visitors and
periodic monitoring by Wood's lamp or by culturing for .
In refractory cases the possibility of an underlying disease should be considered.

Frequent and repeated use of an antimycotic may result in the induction of resistance to
antimycotics of the same class.
Refer to section

i) Special precautions for use in animals
Cats suffering from dermatophytosis, but also in poor general condition and/or suffering
from additional diseases or impaired immunological response should be monitored closely
during treatment. Because of their condition, this category of animals may be more
sensitive to the development of adverse effects. In case of a serious adverse effect,
treatment should be interrupted and supportive care therapy (fluid therapy) should be
initiated if necessary. If clinical signs suggestive of liver dysfunction develop, treatment
should be discontinued immediately. It is very important to monitor liver enzymes in
animals showing signs of liver dysfunction.
In humans, itraconazole has been associated with heart failure due to a negative inotropic
effect. Cats suffering from heart diseases should be carefully monitored and the treatment
should be withdrawn if the clinical signs deteriorate.

Revised: November 2024
AN: 01058/2024
ii) Special precautions to be taken by the person administering the veterinary
medicinal product to animals
If a suspected lesion occurs on a human, consult a physician, since
dermatophytosis is a zoonotic disease. Therefore, wear latex gloves when clipping hair of
infected cats, when handling the animal during treatment or when cleaning the syringe.
Wash hands and exposed skin after use. In case of accidental contact with eyes, rinse
thoroughly with water. In case of pain or irritation, seek medical advice. In case of
accidental ingestion, rinse mouth with water.

Vomiting, hepatic and renal disorders were seen after concomitant treatment of Itrafungol
and cefovecin. Symtoms like motor incoordination, faecal retention and dehydration are
observed when tolfenamic acid and Itrafungol are given simultaneously. Co-administration
of the product and these drugs, in absence of data in cats, should be avoided.
In human medicine, interactions between itraconazole and certain other drugs have been
described, resulting from interactions with cytochrome P450 3A4 (CYP3A4) and P-
glycoproteins (PgP). This may result in increased plasma concentrations of e.g. oral
midazolam, cyclosporin, digoxin, chloramphenicol, ivermectin, or methylprednisolone. The
increased plasma levels can prolong the duration of effects as well as side effects.
Itraconazole may also increase the serum level of oral antidiabetic agents, which may
result in hypoglycaemia..
On the other hand, some drugs, e.g. barbiturates or phenytoin can increase the rate of
metabolism of itraconazole, resulting in a decreased bioavailability, hence a decreased
efficacy. As itraconazole requires an acidic environment for maximal absorption, antacids
cause a marked reduction in absorption. Concomitant use of erythromycin can increase
the plasma concentration of itraconazole.
Interactions in humans between itraconazole and calcium antagonists have also been
reported. These drugs might have additive negative inotropic effects to the heart.
It is not known to what extent these interactions are relevant for cats, but in the absence of
data, co-administration of the product and these drugs should be avoided.

Revised: November 2024
AN: 01058/2024

Do not store above 25°C.
Keep the container tightly closed

For a full list of excipients, see section

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.